Shares of Rocket Lab rebounded +3.8% to $72.10 on Wednesday, defying a red market, after the company landed the largest launch contract in its history. The $190 million deal covers a block buy of 20 hypersonic test flights over four years for a Pentagon program designed to accelerate weapons testing. The move partially recovers Monday's brutal -11.6% selloff — but the real question is whether this contract changes the math for a stock trading at roughly 66x trailing revenue.
• The Pentagon's Hypersonic Testing Bottleneck Is Rocket Lab's Opportunity. The Defense Department's push for hypersonic weapons has been constrained by limited access to flight tests, slowed by cost, range availability, and scheduling — delaying the validation of designs before they reach production. At $9.5 million per flight, Rocket Lab is offering a relatively cheap, rapid-turnaround option. The company boasts a 100% success rate across all prior hypersonic flights since 2023 , which is why the Pentagon is buying in bulk rather than one-off.
• Twenty-Eight Launches Sold in Q1 Alone Signals Demand Is Accelerating. Rocket Lab has sold 28 new launches in Q1 2026 so far — almost as many as the company sold in the full year 2025. That's a dramatic acceleration in booking velocity. The contract increases booked launch backlog and multi-year revenue visibility through 20 pre-sold missions, with combined backlog now exceeding $2 billion. For investors, locked-in future revenue reduces the guesswork — but backlog only matters if it converts to cash on schedule.
• A ~$40 Billion Company Still Losing Money Needs to Prove It Can Execute. Rocket Lab posted $602 million in FY2025 revenue (up 38% year-over-year) but reported an adjusted EBITDA loss of $182 million , largely driven by development spending on its larger, reusable Neutron rocket. Investors also need to weigh the higher backlog against a recently announced stock-sale program of up to $1.75 billion , signaling the company still needs outside capital to fund growth.
• The Neutron Rocket Remains the Make-or-Break Catalyst. Analysts point to Rocket Lab's upcoming medium-lift Neutron rocket — reusable and targeting a larger payload market — now expected to launch in Q4 2026 after a manufacturing delay.
The company's valuation is heavily tied to that first flight; any further delays or a failure would likely trigger a sharp stock correction. Today's hypersonic deal strengthens the near-term story, but it's Neutron that determines whether RKLB grows into its price tag or buckles under it.